- Published at
- by manilatimes.net
mixed
mixed
Barbara Weber, M.D., Elected to ITM Supervisory Board
**media[589978,589979]**
News for Tango Therapeutics, Inc. (TNGX)
- Published at
- by manilatimes.net
negativenegative- Published at
- by zacks.com
negativenegativeTango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates
Tango Therapeutics (TNGX) delivered earnings and revenue surprises of -9.38% and 47.46%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?- Published at
- by manilatimes.net
neutralneutral- Published at
- by gurufocus.com
mixedmixedTango Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Highlights
”“ TNG462 granted Orphan Drug Designation for treatment of pancreatic cancer ”“ ”“ Investigational New Drug (IND) application for TNG456, a next-generation- Published at
- by manilatimes.net
neutralneutral- Published at
- by manilatimes.net
neutralneutral- Published at
- by seekingalpha.com
positivepositiveTNGX: Chance For A Short Squeeze (NASDAQ:TNGX)
Tango Therapeutics is a growing cancer drug development company with partners such as Gilead Sciences. Explore more details here.- Published at
- by gurufocus.com
positivepositiveTango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer- Published at
- by gurufocus.com
neutralneutralTango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer- Published at
- by insidermonkey.com
negativenegativeTango Therapeutics Inc. (TNGX): Among the Most Promising Cancer Stocks According to Hedge Funds
We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In this article, we are going to take a look at where Tango Therapeutics Inc.- Published at
- by investorideas.com
mixedmixed- Published at
- by gurufocus.com
positivepositiveEcoR1 Capital, LLC Adjusts Stake in Tango Therapeutics Inc
On November 7, 2024, EcoR1 Capital, LLC (Trades, Portfolio), a prominent investment firm, made a significant adjustment to its holdings in Tango Therapeutics In- Published at
- by seekingalpha.com
neutralneutralTango stock plunges 28% amid pipeline updates, Q3 earnings report (NASDAQ:TNGX)
Tango Therapeutics (TNGX) stock plunged 28% Wednesday after the company announced updates on several drug candidates and released its Q3 earnings report. Read more here.- Published at
- by rttnews.com
mixedmixedPre-market Movers: DATS, AREB, ZCAR, DJT, VSTE…
New Jersey-based DatChat, Inc. (DATS) is up over 97 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.- Published at
- by zacks.com
positivepositiveTango Therapeutics, Inc. (TNGX) Reports Q3 Loss, Tops Revenue Estimates
Tango Therapeutics (TNGX) delivered earnings and revenue surprises of 20.59% and 44.35%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?- Published at
- by seekingalpha.com
mixedmixedTango Therapeutics: Amgen Missteps Devalue PRMT5 Candidates Ahead Of Critical Data (TNGX)
Tango Therapeutics is a high-risk, high-reward opportunity in the field of PRMT5-inhibitor drugs targeting MTAP-deleted cancers. Read more on TNGX stock here.- Published at
- by globenewswire.com
mixedmixedHOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200
Director Dr. Malte Peters named Chief Executive Officer and Director Terry Coelho named Executive Vice President and Chief Financial OfficerCompany is...- Published at
- by investing.com
mixedmixedTango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights By Investing.com
Tango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights- Published at
- by investing.com
negativenegativeMultibillionaire Joe Lewis to face US sentencing for insider trading By Reuters
Multibillionaire Joe Lewis to face US sentencing for insider trading